News from us and our partners

Tags

Topics

0 results

News
17 November, 2015
Crescendo Biologics Appoints Dr Kevin Johnson as Chairman
News
16 November, 2015
Sofinnova launches BiovelocITA: the first biotech accelerator in Italy
News
11 November, 2015
TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast
News
2 November, 2015
Mainstay Medical Applies for CE Mark for ReActiv8®
News
2 November, 2015
Mainstay Medical Applies for CE Mark for ReActiv8®
News
20 October, 2015
RefleXion Medical Achieves Major Milestones in Development of Biologically-Guided Radiotherapy
News
1 October, 2015
Dow AgroSciences, Synthace research collaboration to accelerate product development using high tech tools
News
29 September, 2015
Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners
News
22 September, 2015
ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer
News
31 August, 2015
Mainstay Medical's ReActiv8-A trial shows positive CLBP data
News
10 July, 2015
Bio World Congress on Industrial Biotechnology
News
1 July, 2015
Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer
News
1 July, 2015
MISSION Therapeutics appoints Dr Colin Goddard to its Board of Directors
News
30 June, 2015
NuCana Appoints Martin J Birkhofer, M.D. as Chief Medical Officer
News
22 June, 2015
Mainstay Medical Strengthens Board with New Independent Director
News
1 June, 2015
Creabilis appoints Catherine Moukheibir as Chairman of its Board of Directors

Crescendo Biologics Appoints Dr Kevin Johnson as Chairman

Sofinnova launches BiovelocITA: the first biotech accelerator in Italy

TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast

Mainstay Medical Applies for CE Mark for ReActiv8®

Mainstay Medical Applies for CE Mark for ReActiv8®

RefleXion Medical Achieves Major Milestones in Development of Biologically-Guided Radiotherapy

Dow AgroSciences, Synthace research collaboration to accelerate product development using high tech tools

Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners

ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer

Mainstay Medical's ReActiv8-A trial shows positive CLBP data

Bio World Congress on Industrial Biotechnology

Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer

MISSION Therapeutics appoints Dr Colin Goddard to its Board of Directors

NuCana Appoints Martin J Birkhofer, M.D. as Chief Medical Officer

Mainstay Medical Strengthens Board with New Independent Director

Creabilis appoints Catherine Moukheibir as Chairman of its Board of Directors